deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02992951

DACC in the REduction of Surgical Site INfection (DRESSINg)

A Randomised Controlled Trial to Assess the Clinical and Cost Effectiveness of Dialkylcarbamoylchloride (DACC) Coated Post-operative Dressings Versus Standard Care in the Prevention of Surgical Site Infection in Clean or Clean-contaminated, Vascular Surgery.

Sponsor: Hull University Teaching Hospitals NHS Trust

Updated 18 times since 2017 Last updated: Jan 28, 2026 Started: Jan 19, 2017 Primary completion: Jun 28, 2025 Completion: Aug 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Infection, Bacterial and Surgical Incision, this trial is completed. The trial is conducted by Hull University Teaching Hospitals NHS Trust and has accumulated 18 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Mar 2023 · 3 months · monthly snapshot~Mar 2023 – ~Apr 2024 · 13 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Apr 2025 · 6 months · monthly snapshot~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshot~Jun 2025 – ~Aug 2025 · 2 months · monthly snapshot~Aug 2025 – ~Feb 2026 · 6 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

18 versions recorded
  1. Feb 2026 — Present [monthly]

    Completed NA

    Status: RecruitingCompleted

  2. Aug 2025 — Feb 2026 [monthly]

    Recruiting NA

  3. Jun 2025 — Aug 2025 [monthly]

    Recruiting NA

  4. Apr 2025 — Jun 2025 [monthly]

    Recruiting NA

  5. Oct 2024 — Apr 2025 [monthly]

    Recruiting NA

Show 13 earlier versions
  1. Sep 2024 — Oct 2024 [monthly]

    Recruiting NA

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  3. Apr 2024 — Jul 2024 [monthly]

    Recruiting NA

  4. Mar 2023 — Apr 2024 [monthly]

    Recruiting NA

  5. Dec 2022 — Mar 2023 [monthly]

    Recruiting NA

  6. Dec 2021 — Dec 2022 [monthly]

    Recruiting NA

    Status: CompletedRecruiting

  7. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  8. Dec 2019 — Jan 2021 [monthly]

    Completed NA

  9. Aug 2019 — Dec 2019 [monthly]

    Completed NA

  10. Feb 2019 — Aug 2019 [monthly]

    Completed NA

    Status: RecruitingCompleted · Phase: PHASE2NA

  11. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  12. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  13. Jan 2017 — Mar 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hull University Teaching Hospitals NHS Trust
  • University of Hull
Data source: Hull University Teaching Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations